Skip to main content

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

TRVI holding history

Trevi Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TRVI overviewAll 13F holders of TRVIFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of TRVI by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−293,300−100.0%Sold outHolders
Q3 2025293,300$2.68M<0.1%−196,000−40.1%ReducedHolders
Q2 2025489,300$2.68M<0.1%+400,400+450.4%AddedHolders
Q1 202588,900$559.2K<0.1%−11,500−11.5%ReducedHolders
Q4 2024100,400$413.6K<0.1%+29,700+42.0%AddedHolders
Q3 202470,700$236.1K<0.1%+18,800+36.2%AddedHolders
Q2 202451,900$154.7K<0.1%−64,942−55.6%ReducedHolders
Q1 2024116,842$403.0K<0.1%−425,858−78.5%ReducedHolders
Q4 2023542,700$727.0K<0.1%+475,400+706.4%AddedHolders
Q3 202367,300$147.0K<0.1%−22,000−24.6%ReducedHolders
Q2 202389,300$213.0K<0.1%−148,100−62.4%ReducedHolders
Q1 2023237,400$439.0K<0.1%−80,600−25.3%ReducedHolders
Q4 2022318,000$614.0K<0.1%−101,187−24.1%ReducedHolders
Q3 2022419,187$646.0K<0.1%+267,687+176.7%AddedHolders
Q2 2022151,500$426.0K<0.1%+35,500+30.6%AddedHolders
Q1 2022116,000$255.0K<0.1%−221,400−65.6%ReducedHolders
Q4 2021337,400$264.0K<0.1%+271,900+415.1%AddedHolders
Q3 202165,500$92.0K<0.1%−27,100−29.3%ReducedHolders
Q2 202192,600$208.0K<0.1%−29,249−24.0%ReducedHolders
Q1 2021121,849$330.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.